NVNO · enVVeno Medical Corp
$11.47
+0.67 (+6.18%)
At close · Aug 26
Market Cap
$7.83M
Shares
682,722
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-07-30 | 2026-06-30 | |
| 8-K | 2026-07-14 | — | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| 8-K | 2026-04-29 | — | |
| 10-K | 2026-03-26 | 2025-12-31 | |
| 8-K | 2026-02-04 | — | |
| 8-K | 2026-01-20 | — | |
| 8-K | 2025-12-12 | 2025-12-11 | |
| 8-K | 2025-11-20 | 2025-11-17 | |
| 8-K | 2025-11-14 | 2025-11-13 | |
| DEF 14A | 2025-10-30 | 2025-12-11 | |
| 10-Q | 2025-10-30 | 2025-09-30 | |
| 8-K | 2025-10-30 | — | |
| 8-K | 2025-10-10 | 2025-10-07 | |
| 8-K | 2025-08-20 | — | |
| 10-Q | 2025-07-31 | 2025-06-30 | |
| 8-K | 2025-05-20 | 2025-05-19 | |
| 10-Q | 2025-04-30 | 2025-03-31 | |
| 8-K | 2025-04-21 | 2025-04-17 | |
| 10-K/A | 2025-02-28 | 2024-12-31 | |
| 10-K | 2025-02-28 | 2024-12-31 | |
| 8-K | 2024-12-26 | 2024-12-18 | |
| DEF 14A | 2024-11-19 | 2024-12-18 | |
| 10-Q | 2024-10-31 | 2024-09-30 | |
| 8-K | 2024-09-30 | 2024-09-26 | |
| 10-Q | 2024-07-31 | 2024-06-30 | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| 8-K | 2024-04-24 | — | |
| 8-K | 2024-03-06 | — | |
| 10-K | 2024-02-29 | 2023-12-31 | |
| 8-K | 2023-12-07 | 2023-12-05 | |
| 8-K | 2023-11-16 | — | |
| DEF 14A | 2023-11-03 | — | |
| 10-Q | 2023-10-26 | 2023-09-30 | |
| 8-K | 2023-10-12 | 2023-10-06 | |
| 10-Q | 2023-07-31 | 2023-06-30 | |
| 10-Q | 2023-04-28 | 2023-03-31 | |
| 10-K | 2023-03-02 | 2022-12-31 | |
| 8-K | 2022-12-06 | 2022-11-30 | |
| DEF 14A | 2022-11-01 | — | |
| 10-Q | 2022-10-27 | 2022-09-30 | |
| 10-Q | 2022-08-03 | 2022-06-30 | |
| 10-Q/A | 2022-05-11 | 2022-03-31 | |
| 10-K/A | 2022-05-11 | 2021-12-31 | |
| 10-Q | 2022-04-29 | 2022-03-31 | |
| 10-K | 2022-03-28 | 2021-12-31 | |
| 8-K/A | 2021-12-03 | 2021-11-30 | |
| 8-K | 2021-12-01 | 2021-11-30 | |
| 10-Q | 2021-11-12 | 2021-09-30 | |
| DEF 14A | 2021-11-02 | 2021-11-01 |
Showing 1–50 of 80 filings
Key facts
CIK
1661053
CUSIP
29415J205
13F (30d)
15 filings
15 filers
Visit website
Investor relations